SciClone PharmaceuticalsMost RecentCompany & Industry OverviewsAgios Announces Data from Phase 2 Study of PK DeficiencyAgios Pharmaceuticals was one of the top performers among the small-cap segment within the iShares Nasdaq Biotechnology ETF (IBB) on June 13, 2016.
Company & Industry OverviewsAgios Announces Data from Phase 2 Study of PK DeficiencyAgios Pharmaceuticals was one of the top performers among the small-cap segment within the iShares Nasdaq Biotechnology ETF (IBB) on June 13, 2016.
